Invasive mycoses: management and unmet medical needs
- 1 December 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 14 (6) , 669-671
- https://doi.org/10.1097/00001432-200112000-00001
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial TherapyAnnals of Internal Medicine, 2001
- Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997Clinical Infectious Diseases, 2001
- Need for Alternative Trial Designs and Evaluation Strategies for Therapeutic Studies of Invasive MycosesClinical Infectious Diseases, 2001
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- Invasive Aspergillosis Disease Spectrum, Treatment Practices, and OutcomesMedicine, 2000
- Practice Guidelines for Diseases Caused by AspergillusClinical Infectious Diseases, 2000
- Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 1999
- An EORTC International Multicenter Randomized Trial (EORTC Number 19923) Comparing Two Dosages of Liposomal Amphotericin B for Treatment of Invasive AspergillosisClinical Infectious Diseases, 1998
- Trends in the postmortem epidemiology of invasive fungal infections at a University HospitalJournal of Infection, 1996